Datasets:

Suchinthana
/

support2-1

Dataset card Data Studio Files Files and versions Community

Split (1)

train · 9.11k rows

ID int64 1 9.11k	age float64 18 102	death int64 0 1	sex stringclasses 2 values	hospdead int64 0 1	slos int64 3 343	d.time int64 3 2.03k	dzgroup stringclasses 8 values	dzclass stringclasses 4 values	num.co int64 0 9	edu float64 0 31 ⌀	income stringclasses 4 values	scoma float64 0 100 ⌀	charges float64 1.17k 1.44M ⌀	totcst float64 0 633k ⌀	totmcst float64 -102.72 711k ⌀	avtisst float64 1 83 ⌀	race stringclasses 5 values	sps float64 0.2 99.2 ⌀	aps float64 0 143 ⌀	surv2m float64 0 0.97 ⌀	surv6m float64 0 0.95 ⌀	hday int64 1 148	diabetes int64 0 1	dementia int64 0 1	ca stringclasses 3 values	prg2m float64 0 1 ⌀	prg6m float64 0 1 ⌀	dnr stringclasses 3 values	dnrday float64 -88 285 ⌀	meanbp float64 0 195 ⌀	wblc float64 0 200 ⌀	hrt float64 0 300 ⌀	resp float64 0 90 ⌀	temp float64 31.7 41.7 ⌀	pafi float64 12 890 ⌀	alb float64 0.4 29 ⌀	bili float64 0.1 63 ⌀	crea float64 0.1 21.5 ⌀	sod float64 110 181 ⌀	ph float64 6.83 7.77 ⌀	glucose float64 0 1.09k ⌀	bun float64 1 300 ⌀	urine float64 0 9k ⌀	adlp float64 0 7 ⌀	adls float64 0 7 ⌀	sfdm2 stringclasses 5 values	adlsc float64 0 7.07
7,601	50.155	0	male	0	19	450	ARF/MOSF w/Sepsis	ARF/MOSF	2	11	under $11k	0	47,488	30,988.4062	36,089.4062	24.333328	white	23.199219	53	0.820923	0.759888	9	1	0	no	0.9	0.9	no dnr	19	73	15.298828	122	36	35.89844	276.1875	2.599609	1	0.899902	135	7.579102	82	10	5,220	null	2	SIP>=30	2
7,602	59.05798	1	male	1	21	21	ARF/MOSF w/Sepsis	ARF/MOSF	1	16	>$50k	0	162,877	101,907.938	133,405.5	47.333313	white	21.796875	48	0.806885	0.74292	11	0	0	no	0.5	0.5	dnr after sadm	21	93	3.699707	120	16	36	null	3.099609	0.299988	1.299805	136	null	86	20	null	null	null	<2 mo. follow-up	2.347656
7,603	58.49399	1	female	0	8	57	Cirrhosis	COPD/CHF/Cirrhosis	1	8	$25-$50k	0	11,768	7,699.5938	10,629.875	14	white	24.898438	31	0.715942	0.55896	1	0	0	no	0.4	0.25	dnr before sadm	-1	117	10.599609	149	36	40.19531	410	null	null	1.099854	139	7.459961	119	18	2,016	0	1	<2 mo. follow-up	1
7,604	78.30499	1	male	1	70	70	MOSF w/Malig	ARF/MOSF	1	null	under $11k	0	207,901	131,304.625	154,790.25	57.5	black	24.898438	56	0.484985	0.366943	14	0	0	metastatic	null	null	dnr after sadm	45	97	6.899414	97	20	35.69531	null	3.699707	0.699951	1.299805	135	null	140	18	2,500	null	0	null	0
7,605	80.18298	1	female	0	10	44	ARF/MOSF w/Sepsis	ARF/MOSF	0	10	under $11k	41	22,539	12,764.4297	15,843.125	28	white	25.796875	57	0.549927	0.435974	1	0	0	no	0.6	0.55	no dnr	10	130	24.699219	98	24	38.59375	348	3.399902	1	0.799927	137	7.479492	348	28	1,200	null	7	<2 mo. follow-up	7
7,606	72.13995	0	male	0	3	449	CHF	COPD/CHF/Cirrhosis	3	12	under $11k	0	4,233	2,018.9502	2,630.51953	null	white	19.796875	24	0.842896	0.741943	1	0	0	no	0.8	0.75	no dnr	3	77	13.798828	200	30	36	null	1.599854	5.199219	1.399902	128	null	59	31	1,275	null	null	no(M2 and SIP pres)	2.484863
7,607	64.05499	1	male	1	7	7	MOSF w/Malig	ARF/MOSF	1	7	under $11k	0	20,604	12,852.2578	15,802.3125	47.5	black	38.09375	55	0.238983	0.13797	1	0	0	metastatic	0.4	0.3	no dnr	7	97	13.699219	72	20	36.29688	252.375	null	null	1.099854	138	7.369141	141	25	2,150	6	6	<2 mo. follow-up	6
7,608	56.50897	1	male	0	6	169	COPD	COPD/CHF/Cirrhosis	2	8	under $11k	0	10,470	6,250.8945	7,410.46875	20	black	27.398438	50	0.820923	0.708984	1	0	0	no	0.4	0.2	no dnr	6	112	19.898438	107	23	38.69531	71.10938	2.5	0.299988	1.5	133	7.489258	141	16	3,316	4	6	SIP>=30	6
7,609	101.84796	0	female	0	3	447	CHF	COPD/CHF/Cirrhosis	4	12	under $11k	0	3,497	1,888.5098	2,297.22852	null	white	23.5	24	0.639893	0.458984	1	0	0	no	0.8	0.5	dnr after sadm	1	65	8	69	24	35.5	null	3.699707	1.5	1.699951	139	null	124	29	2,000	0	4	null	4
7,610	66.22595	1	female	0	16	31	COPD	COPD/CHF/Cirrhosis	4	12	under $11k	0	19,176	12,381.0938	15,893.3125	14	white	23.5	39	0.816895	0.702881	1	0	0	no	0.5	0.4	dnr after sadm	2	118	24.5	114	30	36.29688	200	1.799805	3.599609	5.099609	136	7.479492	344	38	0	5	5	<2 mo. follow-up	5
7,611	55.38699	1	male	1	6	6	Lung Cancer	Cancer	2	8	under $11k	0	4,879	3,245.5215	4,274.38672	8	white	37.398438	28	0.191986	0.016998	1	0	0	metastatic	0.05	0.01	dnr before sadm	-1	128	7.599609	83	24	36.59375	312	3.799805	0.5	2.799805	134	7.479492	277	34	1,625	null	6	<2 mo. follow-up	6
7,612	71.82495	1	male	1	3	3	Lung Cancer	Cancer	4	null	null	0	2,710	1,770.377	2,273.98828	14	white	22.898438	20	0.550903	0.227997	1	0	0	metastatic	0.1	0	dnr after sadm	2	129	24.199219	129	36	38.59375	132.625	4.199219	1	1.099854	137	7.449219	116	8	2,900	null	null	<2 mo. follow-up	4.530273
7,613	79.15094	1	female	0	86	326	Cirrhosis	COPD/CHF/Cirrhosis	4	12	under $11k	0	186,222	null	null	54.75	white	28.5	55	0.434998	0.233978	1	0	0	no	0.2	0.15	dnr after sadm	4	63	10.599609	109	6	37.79688	172.5	1.899902	1.5	1.399902	129	7.519531	189	27	1,705	null	4	adl>=4 (>=5 if sur)	4
7,614	36.13397	1	male	1	8	8	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	94	28,437	17,370.5	20,058.3281	58.5	black	37.296875	68	0.221985	0.123993	2	0	0	no	0.5	0.5	dnr after sadm	5	72	4.5	61	20	36.09375	null	3	0.5	0.799927	135	null	97	7	3,050	null	7	<2 mo. follow-up	7
7,615	38.021	0	female	0	3	445	CHF	COPD/CHF/Cirrhosis	2	11	$11-$25k	0	4,508	2,343.2285	2,808.04883	null	white	7.899414	5	0.969971	0.947998	1	0	0	no	null	null	no dnr	3	103	17	141	28	38.5	190	2.099609	2.899902	0.699951	128	7.509766	99	17	7,495	null	null	no(M2 and SIP pres)	1.792481
7,616	77.72998	1	female	1	8	8	MOSF w/Malig	ARF/MOSF	2	16	under $11k	9	52,972	35,296.4688	45,453.5625	40.5	white	33	40	0.276978	0.168976	21	0	0	yes	0.8	0.6	no dnr	8	80	20.5	68	28	36.5	247.59375	2.799805	1	0.599976	110	7.419922	194	8	1,850	null	0	<2 mo. follow-up	0
7,617	42.17899	1	male	1	16	16	Cirrhosis	COPD/CHF/Cirrhosis	2	12	under $11k	0	65,312	39,065.2188	46,535.9375	53.333313	black	44.59375	98	0.362	0.169983	1	0	0	no	0.5	0.5	no dnr	16	112	6.799805	73	28	36.19531	236	3.099609	0.799927	0.699951	135	7.489258	216	11	2,700	null	1	<2 mo. follow-up	1
7,618	39.81897	0	female	0	6	443	Cirrhosis	COPD/CHF/Cirrhosis	1	16	under $11k	0	5,006	3,479.6816	4,045.34961	9	white	17.296875	11	0.902954	0.835938	1	0	0	no	0.9	0.9	no dnr	6	51	18.898438	156	12	35.79688	105	2.099609	1.5	1.5	134	7.25	245	16	508	0	null	no(M2 and SIP pres)	0.494751
7,619	53.86697	0	male	0	6	441	COPD	COPD/CHF/Cirrhosis	1	5	$11-$25k	0	7,160	4,400.0234	4,707.37891	22	white	19.296875	22	0.910889	0.849976	1	0	0	no	0.6	0.5	no dnr	6	112	12.898438	128	36	36.19531	200	null	0.299988	0.699951	145	7.359375	128	11	1,145	0	0	SIP>=30	0
7,620	51.17297	0	female	0	5	440	COPD	COPD/CHF/Cirrhosis	2	9	under $11k	0	5,386	3,353.3106	3,731.2793	12	white	18.796875	22	0.920898	0.866943	1	0	0	no	0.7	0.6	no dnr	5	74	12.599609	69	26	38	196.65625	null	null	0.899902	136	7.40918	233	36	2,640	0	0	no(M2 and SIP pres)	0
7,621	64.43799	1	female	1	4	4	MOSF w/Malig	ARF/MOSF	3	12	under $11k	100	13,930	9,046.1719	14,161.4453	32	black	26.597656	60	0.133972	0.061996	2	1	0	yes	0.1	0.1	dnr after sadm	1	107	9.298828	65	20	36.29688	null	3.399902	0.699951	1.099854	139	null	89	16	null	null	6	<2 mo. follow-up	6
7,622	76.84296	0	male	0	5	440	CHF	COPD/CHF/Cirrhosis	3	3	under $11k	0	11,660	6,288.6953	8,080.69922	18	black	15.099609	15	0.861938	0.771973	3	0	0	no	0.7	0.5	no dnr	5	108	15.5	126	13	39.29688	212	2.399902	0.399963	1.099854	143	7.329102	101	27	1,958	0	0	null	0
7,623	35.19199	0	female	0	4	439	ARF/MOSF w/Sepsis	ARF/MOSF	1	19	$25-$50k	0	5,861	3,415.1387	4,009.68945	18	black	19.597656	33	0.918945	0.889893	1	1	0	no	0.99	0.98	no dnr	4	65	11.298828	107	26	36.69531	null	2.899902	0.899902	0.799927	133	null	77	18	null	0	null	no(M2 and SIP pres)	0.494751
7,624	61.33298	0	female	0	4	439	CHF	COPD/CHF/Cirrhosis	1	8	under $11k	0	4,118	2,522.3262	2,874.33984	9	black	20.5	33	0.866943	0.778931	1	0	0	no	0.5	0.3	no dnr	4	109	4.5	72	16	36.39844	null	3.399902	2.099609	1.099854	141	null	99	15	2,925	1	null	no(M2 and SIP pres)	1.166748
7,625	73.03497	0	female	0	14	438	COPD	COPD/CHF/Cirrhosis	2	9	under $11k	0	16,154	10,277.6406	11,024.25	10.666664	white	16.597656	32	0.86499	0.775879	1	0	0	no	0.9	0.8	no dnr	14	83	10.199219	76	18	36.69531	null	2.699707	29.097656	2.199707	128	null	94	43	380	2	4	no(M2 and SIP pres)	4
7,626	48.564	0	male	0	5	440	CHF	COPD/CHF/Cirrhosis	3	8	under $11k	0	10,627	null	null	13	hispanic	12.298828	8	0.945923	0.907959	1	1	0	no	0.8	0.7	no dnr	5	149	15.898438	120	12	38.29688	150	3	0.599976	14.699219	139	7.419922	123	46	408	0	null	null	0.494751
7,627	62.95099	1	female	1	8	8	Coma	Coma	0	11	under $11k	94	23,065	14,024.0391	16,236.6797	35	white	17.898438	31	0.435974	0.362	1	0	0	no	0.05	0	dnr after sadm	1	73	16.296875	109	24	36	131.65625	4.599609	1.899902	0.799927	139	7.239258	110	24	1,350	null	0	<2 mo. follow-up	0
7,628	56.65399	0	male	0	4	437	COPD	COPD/CHF/Cirrhosis	4	9	$11-$25k	0	3,524	2,321.0527	3,062.57812	9	white	13	13	0.939941	0.897949	1	1	0	no	0.9	0.8	no dnr	4	67	0.109985	114	20	35.39844	null	2.699707	0.899902	1	132	null	193	10	5,550	0	null	SIP>=30	0.494751
7,629	33.72998	1	male	0	6	108	Lung Cancer	Cancer	3	8	under $11k	0	6,140	4,036.418	4,984.34766	17	white	25	14	0.613892	0.297974	1	0	0	metastatic	0.8	0.5	no dnr	6	73	null	120	32	36.29688	null	3.199707	0.399963	1.299805	135	null	95	23	2,025	2	3	SIP>=30	3
7,630	73.03796	0	male	0	29	436	ARF/MOSF w/Sepsis	ARF/MOSF	3	14	$11-$25k	0	108,958	67,792	75,865.125	32.25	white	13.699219	14	0.868896	0.822998	8	0	0	no	0.9	0.9	no dnr	29	108	14.599609	79	30	36.89844	252	3.399902	1.599854	1.599854	142	7.5	168	29	2,515	null	1	no(M2 and SIP pres)	1
7,631	65.34998	0	male	0	7	436	CHF	COPD/CHF/Cirrhosis	4	9	under $11k	0	7,626	5,014.125	5,407.1875	7.5	white	10.699219	17	0.91394	0.85498	1	1	0	yes	0.9	0.8	no dnr	7	74	10.599609	98	24	34.5	null	3.299805	0.799927	1.199951	131	null	121	19	725	1	null	no(M2 and SIP pres)	1.166748
7,632	81.27295	1	female	1	6	6	ARF/MOSF w/Sepsis	ARF/MOSF	6	12	$11-$25k	100	15,340	9,386.2031	10,665.7734	46	white	35.695313	78	0.042	0.011999	1	1	1	no	null	null	dnr after sadm	2	51	22	64	16	36.09375	295.1875	null	1.199951	1.299805	134	7.539062	254	29	1,300	null	6	<2 mo. follow-up	6
7,633	51.11298	0	male	0	14	435	COPD	COPD/CHF/Cirrhosis	2	14	under $11k	0	31,211	19,024.2031	22,263.8438	20	black	28.199219	44	0.839966	0.736938	1	0	0	no	0.6	0.6	no dnr	14	74	10.199219	92	36	36	380.9375	2.799805	5.299805	1.699951	132	7.419922	108	38	1,625	null	3	no(M2 and SIP pres)	3
7,634	59.61899	0	female	0	24	434	ARF/MOSF w/Sepsis	ARF/MOSF	2	6	under $11k	0	57,393	34,737.5312	43,643.9375	28.333328	white	27.699219	57	0.74292	0.662964	3	1	0	no	0.9	0.9	no dnr	24	65	8.5	104	24	39	200	2.899902	16.097656	1.399902	136	7.489258	127	22	2,250	0	0	no(M2 and SIP pres)	0
7,635	74.02899	1	female	1	6	6	Cirrhosis	COPD/CHF/Cirrhosis	1	9	under $11k	9	26,218	17,460.0938	20,449.5781	34	black	26.699219	42	0.297974	0.120987	13	0	0	yes	0.75	0.7	dnr before sadm	-11	61	7.699219	122	10	38.09375	150	1.199951	1.5	1.199951	131	7.379883	103	12	1,120	null	2	<2 mo. follow-up	2
7,636	59.38397	1	female	0	15	91	Lung Cancer	Cancer	3	10	under $11k	0	17,749	11,602.1875	14,856.5391	12.333328	white	33.695313	25	0.279968	0.042999	1	0	0	metastatic	0.8	0.4	dnr before sadm	-1	0	14.5	0	0	38.89844	79	2.599609	1.199951	6.799805	140	7.029297	136	45	0	4	5	SIP>=30	5
7,637	62.612	1	female	1	12	12	ARF/MOSF w/Sepsis	ARF/MOSF	3	10	under $11k	0	56,654	36,087.9375	41,511.9688	49.5	white	38.5	84	0.428955	0.30896	7	0	0	no	0.3	0.3	dnr after sadm	9	93	11.798828	94	24	36.19531	237.03125	4	0.299988	0.799927	135	7.439453	144	9	1,275	null	6	<2 mo. follow-up	6
7,638	73.91595	0	female	0	9	433	CHF	COPD/CHF/Cirrhosis	5	10	under $11k	0	6,936	5,204.4727	5,641.50781	7.5	black	21.5	21	0.814941	0.700928	1	1	0	no	0.9	0.7	no dnr	9	152	8.898438	73	28	35.69531	191.40625	3.399902	0.899902	1.5	138	7.459961	134	40	1,200	1	0	adl>=4 (>=5 if sur)	0
7,639	79.88794	1	male	0	11	16	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	null	44	38,565	23,817.125	28,461.7031	42	white	23	30	0.554932	0.441956	4	1	0	no	0.1	0.05	dnr after sadm	9	111	4.199219	83	24	36.09375	null	2.899902	0.5	1.099854	135	null	133	8	null	null	0	<2 mo. follow-up	0
7,640	62.81998	1	male	0	7	424	CHF	COPD/CHF/Cirrhosis	3	12	$11-$25k	0	6,640	4,745.4609	5,477.83984	8	white	14	32	0.916992	0.858887	1	1	0	no	0.7	0.6	no dnr	7	167	16.796875	120	24	38.69531	275	3.799805	1.199951	1.199951	137	7.529297	231	27	1,518	0	0	no(M2 and SIP pres)	0
7,641	62.08099	1	female	1	44	44	Coma	Coma	1	12	null	55	73,327	45,294.6875	54,483.9375	35.5	white	23.699219	36	0.474976	0.401978	1	0	0	no	0.1	0.1	dnr after sadm	14	109	4.899414	107	10	38	112	2.199707	0.699951	0.599976	136	7.469727	192	6	2,145	null	0	<2 mo. follow-up	0
7,642	54.45599	0	male	0	9	431	COPD	COPD/CHF/Cirrhosis	3	11	under $11k	0	10,217	6,392.75	6,985.78906	7.5	white	17.796875	24	0.918945	0.863892	1	0	0	no	0.8	0.7	no dnr	9	141	13.099609	126	10	36.29688	268.5625	3.599609	0.299988	0.699951	136	7.399414	167	24	1,590	2	null	null	1.838867
7,643	79.33197	1	female	0	19	146	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	under $11k	9	40,059	26,422.0469	31,716.2344	17.666656	white	26.597656	40	0.634888	0.531982	3	0	0	no	0.75	0.5	dnr after sadm	9	115	5.799805	171	34	38.5	180	2.599609	2.899902	0.599976	127	7.469727	103	16	6,990	4	0	no(M2 and SIP pres)	0
7,644	61.45898	0	male	0	3	429	COPD	COPD/CHF/Cirrhosis	2	12	under $11k	0	3,372	1,992.3457	2,411.76953	null	white	17.597656	33	0.899902	0.830933	1	0	0	no	0.9	0.5	no dnr	3	134	11.599609	105	8	38.79688	192.5	2.699707	0.599976	2.5	143	7.429688	284	51	1,386	0	null	null	0.494751
7,645	85.80194	0	female	0	12	427	COPD	COPD/CHF/Cirrhosis	2	12	under $11k	0	17,244	11,318.9609	12,774.75	15.5	white	18.097656	32	0.773926	0.638916	1	0	0	no	null	null	no dnr	12	67	12.099609	66	15	36.39844	null	3.599609	0.599976	0.799927	131	null	348	10	3,300	0	0	no(M2 and SIP pres)	0
7,646	69.96899	0	male	0	4	428	COPD	COPD/CHF/Cirrhosis	2	8	under $11k	9	5,496	3,477.2148	4,010.05859	13	white	20.699219	24	0.812988	0.696899	1	0	0	no	0.6	0.6	no dnr	4	70	23.296875	106	40	38.09375	795.125	1.799805	0.899902	0.599976	134	7.469727	88	12	2,290	null	null	SIP>=30	3.818848
7,647	49.80698	1	female	0	9	32	Lung Cancer	Cancer	1	12	$11-$25k	0	11,255	7,635.7148	9,128.69531	23.5	black	38.59375	32	0.177979	0.014	1	0	0	metastatic	0.4	0.15	no dnr	9	83	14.199219	122	22	35.89844	347.5625	4	1	1.599854	136	7.469727	140	44	null	1	null	<2 mo. follow-up	1.166748
7,648	54.57898	1	female	0	7	163	Cirrhosis	COPD/CHF/Cirrhosis	5	10	under $11k	9	7,291	4,929.8164	5,425.98828	5.5	black	19.699219	28	0.753906	0.611938	1	1	0	yes	0.6	0.5	no dnr	7	108	15.099609	120	8	36.89844	147.5	3.899902	1.299805	2.299805	143	7.419922	192	64	1,968	2	1	SIP>=30	1
7,649	49.94397	1	female	0	14	120	Colon Cancer	Cancer	3	12	under $11k	0	15,414	11,019.7266	15,135.6641	11.333328	black	31.5	26	0.572998	0.251953	1	1	0	metastatic	0.8	0.6	no dnr	14	129	20.199219	67	28	38.5	null	4.099609	0.899902	1.199951	139	7.489258	100	39	1,062	0	0	no(M2 and SIP pres)	0
7,650	78.59296	0	female	0	16	425	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$11-$25k	37	63,650	40,586.125	47,436.3125	22.333328	white	28.898438	34	0.397949	0.278992	9	0	0	no	0.85	0.85	no dnr	16	70	null	72	22	35.19531	null	3.899902	0.799927	1	138	null	141	12	1,600	null	1	no(M2 and SIP pres)	1
7,651	22.894	0	female	0	21	425	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	under $11k	0	65,950	43,141.9062	51,065.0625	40.666657	black	24.898438	50	0.875	0.829956	9	0	0	no	0.9	0.9	no dnr	21	67	9.898438	68	24	36.59375	180.9375	3.699707	1.799805	0.699951	136	7.40918	240	18	1,925	null	1	no(M2 and SIP pres)	1
7,652	46.06198	0	female	0	25	424	MOSF w/Malig	ARF/MOSF	1	12	under $11k	0	57,769	0	0	15.75	white	22.296875	33	0.702881	0.612915	6	0	0	yes	0.8	0.7	no dnr	25	73	10.298828	73	24	36.09375	null	4	0.5	1	136	null	137	20	null	1	1	SIP>=30	1
7,653	76.70898	1	female	0	16	42	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	under $11k	9	29,230	18,786.9844	21,633.8281	27	white	28.597656	43	0.641968	0.540894	1	0	1	no	0.1	0.1	dnr after sadm	1	123	13.599609	124	20	36.79688	193.53125	4.399414	0.399963	1.5	142	7.429688	200	36	1,675	null	7	<2 mo. follow-up	7
7,654	64.21899	1	male	1	4	4	Colon Cancer	Cancer	2	10	under $11k	26	4,376	2,553.582	3,305.37891	8	black	55.296875	69	0.002	0	1	0	0	metastatic	0	0	dnr before sadm	-1	123	2	141	36	38.59375	157.125	2.299805	2.799805	0.799927	144	7.259766	344	22	2,710	null	null	<2 mo. follow-up	2.698242
7,655	46.53497	0	female	0	13	422	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	0	17,345	10,715.5078	13,619.1172	24	black	24.796875	35	0.852905	0.80188	1	0	0	no	0.9	0.5	no dnr	13	120	13.398438	129	28	37.59375	245.6875	2.099609	0.699951	0.799927	137	7.439453	298	11	1,594	6	5	no(M2 and SIP pres)	5
7,656	72.04095	1	male	0	11	36	Lung Cancer	Cancer	3	11	under $11k	0	8,729	6,092.3672	7,296.08984	6	black	21.097656	30	0.5979	0.278992	1	0	0	metastatic	0.4	0.2	dnr after sadm	5	69	4.5	140	44	38.5	277.75	2.799805	2.299805	1.699951	127	7.509766	194	32	null	0	0	<2 mo. follow-up	0
7,657	61.28998	1	male	1	8	8	MOSF w/Malig	ARF/MOSF	2	null	null	94	15,891	11,420.1797	15,806.625	4	black	23.796875	39	0.097992	0.039993	13	1	0	metastatic	0.05	0	dnr before sadm	-12	77	11.199219	120	20	35.69531	304.75	null	null	0.899902	139	7.359375	159	23	3,100	null	null	<2 mo. follow-up	5.305664
7,658	72.01398	1	male	0	10	40	Cirrhosis	COPD/CHF/Cirrhosis	4	12	$11-$25k	0	10,015	6,940.5156	8,144.29688	11.5	white	25.699219	27	0.586914	0.394958	1	1	0	no	0.5	0.4	dnr after sadm	2	70	9.199219	64	28	37.59375	485.6875	2.5	2.299805	0.599976	135	7.419922	170	9	3,075	null	3	<2 mo. follow-up	3
7,659	39.228	1	male	0	44	230	MOSF w/Malig	ARF/MOSF	1	12	under $11k	0	135,498	87,864.1875	106,784.25	43	white	32.796875	32	0.323975	0.208984	17	0	0	metastatic	0.5	0.4	no dnr	44	122	15.898438	116	38	38.69531	245.6875	2	0.699951	3.5	131	7.509766	95	61	1,175	null	0	no(M2 and SIP pres)	0
7,660	79.81097	1	male	0	6	254	CHF	COPD/CHF/Cirrhosis	3	8	under $11k	0	5,842	3,620.1133	4,259.99609	15	white	15.898438	20	0.861938	0.771973	1	0	0	no	0.6	0.5	no dnr	6	72	15.099609	110	26	36.59375	191.65625	3.799805	0.799927	0.699951	134	7.289062	298	16	3,935	0	0	SIP>=30	0
7,661	68	1	female	1	3	3	Coma	Coma	1	null	null	100	14,464	9,795.5312	12,048.4766	null	white	17.796875	31	0.305969	0.234985	3	1	0	no	null	null	dnr after sadm	3	102	7.699219	104	20	36	290.4375	4	0.5	1.199951	141	7.439453	93	12	null	null	null	<2 mo. follow-up	2.728516
7,662	82.82794	1	female	0	18	23	Cirrhosis	COPD/CHF/Cirrhosis	3	12	under $11k	9	15,211	10,818.75	12,201.375	12.333328	white	24.796875	53	0.368958	0.174988	1	0	0	yes	0.3	0.2	dnr after sadm	1	77	16.898438	61	24	35.79688	266.625	null	null	1.099854	131	7.509766	223	19	null	null	2	<2 mo. follow-up	2
7,663	38.98199	1	female	0	20	274	ARF/MOSF w/Sepsis	ARF/MOSF	6	11	under $11k	9	26,427	17,700.375	20,262.0625	19.666656	white	30.597656	73	0.726929	0.642944	1	1	0	yes	0.8	0.75	no dnr	20	113	9.298828	78	20	36.29688	null	4.099609	0.799927	2.099609	137	null	105	35	2,275	5	6	no(M2 and SIP pres)	6
7,664	55.91498	1	male	1	58	58	MOSF w/Malig	ARF/MOSF	2	12	$11-$25k	9	131,906	null	null	38.75	white	28.097656	44	0.580933	0.470947	1	1	0	yes	null	null	dnr after sadm	46	107	17.199219	133	10	39.19531	170	3.099609	9.699219	2.599609	144	7.469727	166	67	1,820	null	0	<2 mo. follow-up	0
7,665	86.72699	0	female	0	13	415	CHF	COPD/CHF/Cirrhosis	3	12	under $11k	9	23,290	15,441.0625	17,573.125	26.5	white	13	26	0.855957	0.762939	1	0	0	no	0.8	0.6	no dnr	13	105	16.097656	137	26	37.89844	217.125	3.399902	0.5	1.099854	135	7.399414	166	19	1,100	1	1	adl>=4 (>=5 if sur)	1
7,666	57.40997	0	male	0	48	415	ARF/MOSF w/Sepsis	ARF/MOSF	1	10	$11-$25k	37	69,865	45,832.9062	51,862.625	28.25	white	24.398438	37	0.721924	0.636963	1	0	0	no	0.2	0.1	no dnr	48	66	1.799805	118	22	39.09375	null	2.599609	0.799927	1.5	138	null	90	8	null	null	null	no(M2 and SIP pres)	2.857422
7,667	41.84	0	female	0	45	413	ARF/MOSF w/Sepsis	ARF/MOSF	1	13	under $11k	0	139,684	0	0	52.75	white	24	24	0.855957	0.805908	3	0	0	no	0.9	0.9	no dnr	45	70	18.199219	107	10	36.69531	267.5	2.299805	0.399963	0.599976	134	7.359375	156	8	1,584	null	0	adl>=4 (>=5 if sur)	0
7,668	59.439	1	female	0	12	97	ARF/MOSF w/Sepsis	ARF/MOSF	4	12	under $11k	0	23,150	0	0	31	white	21	28	0.859985	0.81189	1	0	0	no	0.8	0.7	no dnr	12	66	8.798828	127	27	38.59375	246.65625	2.699707	1.099854	5.099609	139	7.40918	128	67	270	0	null	SIP>=30	0.494751
7,669	68	0	female	0	41	413	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	under $11k	41	99,097	64,199.9688	78,407.3125	42.75	white	16.398438	16	0.747925	0.668945	9	0	0	no	0.85	0.9	no dnr	41	76	7.899414	129	30	36.59375	220	2.599609	1.399902	0.599976	136	7.469727	118	9	4,375	null	0	adl>=4 (>=5 if sur)	0
7,670	57.91898	1	male	1	78	78	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	$11-$25k	0	186,135	null	null	35	white	26.097656	50	0.723999	0.638916	39	1	0	no	0.9	0.8	dnr after sadm	6	80	null	76	20	38.5	null	null	null	null	140	null	null	null	4,100	null	5	null	5
7,671	50.51599	0	male	0	24	413	Coma	Coma	2	12	under $11k	41	56,631	0	0	27.666656	black	15.798828	27	0.75	0.702881	6	0	0	no	0.65	0.65	no dnr	24	74	1	57	24	38	null	2.199707	0.699951	1.199951	130	null	163	24	null	null	0	null	0
7,672	63.92599	0	female	0	4	410	Cirrhosis	COPD/CHF/Cirrhosis	3	10	under $11k	0	3,902	0	0	8	black	16.699219	7	0.817993	0.703979	1	0	0	no	1	0.98	no dnr	4	59	13.398438	129	36	38.5	151.40625	2	0.799927	0.599976	134	7.439453	316	5	5,730	null	null	no(M2 and SIP pres)	2.470703
7,673	67.70398	0	female	0	7	407	COPD	COPD/CHF/Cirrhosis	5	null	null	0	15,639	9,370.6797	10,751.0469	15.5	white	18	23	0.841919	0.73999	1	1	0	yes	0.9	0.8	no dnr	7	82	17.398438	72	24	36.69531	228.5625	3.199707	0.299988	1.099854	134	7.279297	322	16	2,250	null	null	null	4.359375
7,674	54.93997	1	female	0	38	54	Coma	Coma	2	11	under $11k	0	38,899	26,061.3438	28,384.9531	18.25	white	15.898438	10	0.830933	0.796997	1	1	0	yes	0.3	0.1	dnr after sadm	25	132	6.099609	73	27	38.19531	177.5	2.399902	0.699951	6.299805	139	7.5	176	80	1,390	null	3	<2 mo. follow-up	3
7,675	64.68695	1	male	0	6	250	CHF	COPD/CHF/Cirrhosis	6	7	$11-$25k	0	7,166	4,626.8594	4,966.05859	21	white	23.097656	54	0.826904	0.716919	1	1	0	no	0.5	0.4	no dnr	6	67	19.5	112	35	38.79688	266.625	1.799805	1.299805	1.199951	145	7.469727	154	31	1,881	0	5	no(M2 and SIP pres)	5
7,676	41.29797	1	male	1	21	21	ARF/MOSF w/Sepsis	ARF/MOSF	0	18	>$50k	0	113,373	71,772.75	91,983.125	48	white	22	56	0.86792	0.821899	5	0	0	no	0.3	0.2	dnr after sadm	17	106	6.399414	73	20	36.39844	357.125	3.599609	11.898438	0.599976	152	7.469727	137	12	4,010	null	0	<2 mo. follow-up	0
7,677	69.06195	0	male	0	3	405	CHF	COPD/CHF/Cirrhosis	4	12	$11-$25k	0	5,951	3,269.6738	3,922.03906	null	white	12.099609	19	0.896973	0.826904	1	0	0	yes	0.75	0.7	no dnr	3	114	13.599609	127	47	38.59375	263.3125	1.599854	3.5	0.899902	137	7.479492	201	30	2,010	0	0	no(M2 and SIP pres)	0
7,678	69.79095	0	male	0	53	404	Cirrhosis	COPD/CHF/Cirrhosis	2	12	under $11k	0	64,291	null	null	13	white	19.199219	15	0.744995	0.598999	1	0	0	no	0.8	0.6	no dnr	53	59	14.5	116	40	38.09375	200	2.799805	0.299988	1	130	7.459961	156	21	1,564	7	null	SIP>=30	5.199219
7,679	64.047	1	female	0	10	345	CHF	COPD/CHF/Cirrhosis	2	12	under $11k	0	16,228	10,813.0156	12,048.0938	9.5	white	23.296875	39	0.804932	0.68396	3	0	0	no	0.8	0.6	no dnr	10	71	5.699219	83	20	35.5	null	null	null	1.899902	137	null	181	24	null	4	0	SIP>=30	0
7,680	82.47498	1	male	0	33	350	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	under $11k	9	44,225	29,886.6406	33,524.9688	23	white	30.5	60	0.560913	0.448975	1	0	1	no	0.8	0.6	no dnr	33	122	3.099609	212	44	36.29688	98.32812	2.099609	1.299805	0.699951	134	7.379883	114	16	1,750	null	null	no(M2 and SIP pres)	6.291992
7,681	64.745	0	male	0	5	401	CHF	COPD/CHF/Cirrhosis	4	12	$11-$25k	0	3,720	2,660.5898	2,788.21875	4	white	12.5	13	0.922974	0.868896	1	0	0	no	0.6	0.6	no dnr	5	64	14.5	118	45	36.09375	153.5625	4	0.5	0.699951	138	7.299805	143	10	830	3	3	no(M2 and SIP pres)	3
7,682	49.54999	1	female	0	211	395	ARF/MOSF w/Sepsis	ARF/MOSF	4	10	$25-$50k	0	500,572	null	null	51.75	white	23.398438	37	0.859985	0.810913	1	0	0	no	0.5	0.4	no dnr	211	83	9.798828	72	20	35.79688	225.90625	3.099609	0.699951	1.899902	132	7.419922	92	25	null	null	4	adl>=4 (>=5 if sur)	4
7,683	79.27197	0	male	0	14	398	ARF/MOSF w/Sepsis	ARF/MOSF	4	0	under $11k	9	20,713	12,282.9062	13,829.3828	11.333328	hispanic	30.699219	53	0.573975	0.462952	1	1	1	no	0.5	0.5	no dnr	14	119	6.699219	120	24	35.79688	92	4	0.399963	0.799927	139	7.40918	166	17	1,025	null	null	no(M2 and SIP pres)	6.339844
7,684	33.19098	0	female	0	32	398	ARF/MOSF w/Sepsis	ARF/MOSF	0	16	null	0	102,718	67,687.6875	87,003.5625	37	white	23.097656	18	0.897949	0.860962	1	0	0	no	0.3	0.3	no dnr	32	75	null	118	12	35.89844	null	2.199707	0.399963	0.699951	136	null	108	6	2,200	null	1	SIP>=30	1
7,685	79.55096	1	male	0	4	240	CHF	COPD/CHF/Cirrhosis	6	0	under $11k	0	3,952	2,600.4746	2,707.93945	12	black	20.699219	22	0.803955	0.68396	1	0	0	no	0.6	0.4	no dnr	4	62	19.097656	118	20	38.39844	315.6875	3.199707	1.299805	1.099854	136	7.469727	92	7	null	1	1	no(M2 and SIP pres)	1
7,686	58.40097	0	female	0	18	397	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	under $11k	0	26,552	17,132.6406	19,493.7969	23.333328	black	20.199219	32	0.784912	0.714966	2	0	0	metastatic	0.5	0.08	no dnr	18	131	5.199219	128	28	38.5	115.98438	2.399902	0.799927	1.799805	135	7.359375	123	51	3,845	1	1	no(M2 and SIP pres)	1
7,687	70.784	1	male	0	6	135	Lung Cancer	Cancer	1	11	$11-$25k	0	17,307	10,759.3359	12,718.4688	19	white	26.699219	20	0.449951	0.13797	1	0	0	metastatic	0.7	0.2	no dnr	6	52	7.799805	232	43	39.09375	67	2.5	0.399963	0.5	144	7.30957	172	16	584	0	0	adl>=4 (>=5 if sur)	0
7,688	47.09698	1	male	1	45	45	COPD	COPD/CHF/Cirrhosis	2	11	under $11k	55	170,334	null	null	44.75	hispanic	38.796875	62	0.390991	0.194977	4	0	0	no	0.95	1	no dnr	45	85	9.199219	70	20	36.79688	null	3.899902	0.399963	1.399902	137	null	104	14	null	null	6	<2 mo. follow-up	6
7,689	48.74698	0	female	0	13	396	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	$11-$25k	0	30,269	18,756.7812	22,176.875	27	white	28.296875	49	0.80188	0.735962	1	0	0	no	1	1	no dnr	13	112	0.529907	135	24	39.79688	null	3.199707	1.199951	1	128	null	236	11	null	null	0	no(M2 and SIP pres)	0
7,690	73.74896	1	male	1	22	22	ARF/MOSF w/Sepsis	ARF/MOSF	0	null	null	0	61,904	38,719.8438	44,913.9688	54	white	32.898438	64	0.592896	0.483948	1	0	0	no	0	0	dnr after sadm	3	165	17.398438	144	40	35	54	1.899902	5.5	1.5	134	7.189453	206	11	1,013	null	null	<2 mo. follow-up	2.445313
7,691	61.85397	0	male	0	18	396	ARF/MOSF w/Sepsis	ARF/MOSF	0	11	under $11k	0	62,548	35,952.625	46,691.25	48	white	32.898438	62	0.600952	0.493958	5	0	0	no	0.5	0.5	no dnr	18	98	5.5	76	24	36.29688	null	2.699707	3	0.699951	139	null	64	7	2,100	null	0	adl>=4 (>=5 if sur)	0
7,692	70.771	1	male	0	14	19	COPD	COPD/CHF/Cirrhosis	4	11	$11-$25k	44	12,505	8,552.2188	9,537.1875	11	white	40	40	0.184998	0.052994	1	0	0	no	0.7	0.5	dnr before sadm	-1	77	7	68	24	36	186.65625	null	null	0.699951	139	7.429688	167	16	3,800	null	7	<2 mo. follow-up	7
7,693	40.159	0	male	0	9	396	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	under $11k	0	15,154	10,078.6094	11,145.4531	18.5	white	28.097656	18	0.830933	0.773926	1	0	0	no	1	1	no dnr	9	106	9.599609	67	24	36.59375	182.375	3.699707	0.5	0.599976	131	7.349609	113	12	null	0	0	no(M2 and SIP pres)	0
7,694	71.47699	1	male	1	13	13	ARF/MOSF w/Sepsis	ARF/MOSF	3	8	under $11k	0	68,154	42,684.25	54,392.2188	61	white	25.898438	43	0.723999	0.638916	3	1	1	no	0.3	0.3	no dnr	13	63	33.5	140	44	40.29688	null	2.799805	0.299988	1.399902	146	null	244	32	1,450	null	0	<2 mo. follow-up	0
7,695	37.60397	0	female	0	24	392	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	37	53,459	33,585.25	37,889.9688	28.666656	black	27.097656	41	0.759888	0.682983	1	0	0	no	1	1	no dnr	24	117	8	61	24	36.59375	null	null	null	1.099854	138	null	139	19	1,650	null	0	no(M2 and SIP pres)	0
7,696	64.57996	0	female	0	5	393	CHF	COPD/CHF/Cirrhosis	4	12	under $11k	0	6,380	4,103.3086	4,945.70703	7	hispanic	14.798828	24	0.907959	0.844971	1	0	0	no	0.9	0.8	no dnr	5	62	8.798828	76	24	36.69531	263.875	2.5	0.299988	4.899414	135	7.389648	138	57	3,680	1	null	SIP>=30	1.166748
7,697	54.62799	0	female	0	6	391	Colon Cancer	Cancer	1	13	$25-$50k	0	7,690	5,136.7578	6,230.58984	13	white	7.599609	11	0.918945	0.81189	1	0	0	metastatic	0.8	0.5	no dnr	6	57	7.799805	100	24	35.5	309.5	null	0.5	1.399902	141	7.449219	122	23	null	0	0	SIP>=30	0
7,698	66.61499	0	male	0	6	391	Lung Cancer	Cancer	2	13	under $11k	0	null	null	null	3	black	8.898438	15	0.833984	0.637939	1	0	0	metastatic	0.4	0.3	null	null	114	14.099609	118	24	36.29688	263.75	4.299805	0.299988	1.399902	137	7.429688	355	30	1,000	0	1	SIP>=30	1
7,699	58.11099	1	female	1	13	13	MOSF w/Malig	ARF/MOSF	1	null	under $11k	0	17,463	0	0	19.5	white	32.398438	52	0.417969	0.297974	1	0	0	metastatic	0.4	0.2	dnr before sadm	-1	107	6.599609	67	20	36.19531	407.5625	4.099609	1.399902	0.899902	141	7.429688	197	13	null	null	4	<2 mo. follow-up	4
7,700	42.51599	0	male	0	12	388	Cirrhosis	COPD/CHF/Cirrhosis	3	12	under $11k	9	30,221	19,361.6875	22,055.5469	31	white	30.796875	31	0.68396	0.515991	1	0	0	no	0.9	0.5	no dnr	12	117	11.5	77	36	38.39844	200	2.599609	0.599976	1	150	7.469727	232	23	2,753	0	0	no(M2 and SIP pres)	0

Subsets and Splits

No community queries yet

The top public SQL queries from the community will appear here once available.